Tobacco and Public Health
Insights, analysis and commentary on tobacco control and commercial determinants of health from the Tobacco Control Research Group. The opinions expressed on our blog belong to the authors and should not be seen to necessarily represent TCRG or the University of Bath.
Keep up to date with new posts
SubscribeLatest posts
-
-
-
-
-
-
-
The public health implications of tobacco industry pricing
Governments need to be far more sophisticated in the way that they monitor cigarette prices. Using weighted average prices will help but it is also essential to monitor price trends by price segment.
-
Emergency asthma admissions drop by nearly 2000 a year following smokefree law
Numbers of adults admitted to hospital for emergency treatment for asthma have dropped by over four per cent since smokefree legislation was introduced in England, Bath researchers have found.
-
New research suggests that government cap cigarette prices and raise an extra £500m per year in doing so
Dr Robert Branston, from the Centre for Governance and Regulation at the University of Bath’s School of Management; and Professor Anna Gilmore, from the University’s Department for Health and the UK Centre for Tobacco Control Studies, say that capping the pre-tax cigarette manufacturers’ prices would safeguard society from the market failure behind manufacturers’ pricing power and associated high profits.
-
New research explains why Corporate Social Responsibility is unlikely to change Big Tobacco
It’s now widely accepted that tobacco companies use corporate social responsibility (CSR) initiatives to influence policymakers and weaken public health policies. Until now what tobacco industry executives think about this and what it tells us about the limits of tobacco companies’ CSR programmes has been a mystery. For the first time researchers at the University of Bath have been able to explore this question using internal British American Tobacco (BAT) documents.
Follow us
